169943-40-2

Basic information

• Product Name: N-METHYL-N-(4-PHENOXYBENZYL)AMINE
• Synonyms: N-METHYL-N-(4-PHENOXYBENZYL)AMINE;N-Methyl-N-(4-phenoxybenzyl)amine 97%;N-methyl-1-(4-phenoxyphenyl)methanamine(SALTDATA: FREE);N-Methyl-4-phenoxybenzylamine 97%;N-Methyl-4-phenoxybenzylaMine;N-Methyl-1-(4-phenoxyphenyl)methylamine;N-Methyl-1-(4-phenoxyphenyl)MethanaMine;N-methyl-4-phenoxyBenzenemethanamine
• CAS NO: 169943-40-2
• Molecular Formula: C₁₄H₁₅NO
• Molecular Weight: 213.27
• Mol File: 169943-40-2.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 311.2°Cat760mmHg
• Flash Point: 128.2°C
• Appearance: /
• Density: 1.057g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.567
• CAS DataBase Reference: N-METHYL-N-(4-PHENOXYBENZYL)AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: N-METHYL-N-(4-PHENOXYBENZYL)AMINE(169943-40-2)
• EPA Substance Registry System: N-METHYL-N-(4-PHENOXYBENZYL)AMINE(169943-40-2)

Safety Data

• Hazardous Substances Data: 169943-40-2(Hazardous Substances Data)

Usage

General Description

N-Methyl-N-(4-phenoxybenzyl)amine is a chemical compound with the molecular formula C15H16N. It is a tertiary amine derivative and is commonly used as a building block in organic synthesis. It is a colorless to pale yellow liquid with a faint odor, and it is soluble in organic solvents. N-METHYL-N-(4-PHENOXYBENZYL)AMINE is widely used in the pharmaceutical industry as an intermediate in the production of various drugs and bioactive molecules. It is also used in the synthesis of pesticides, dyes, and other organic compounds. N-Methyl-N-(4-phenoxybenzyl)amine is considered to be of low toxicity, but proper handling and storage procedures should be followed in order to minimize the risks associated with its use.

InChI:InChI=1/C14H15NO/c1-15-11-12-7-9-14(10-8-12)16-13-5-3-2-4-6-13/h2-10,15H,11H2,1H3

Upstream product

• 67-36-7 4-phenoxy benzaldehyde 
• 56553-60-7 sodium tris(acetoxy)borohydride 
• 74-89-5 methylamine 

Relevant articles and documents

Substituted alpha-aminosulphonyl-acetohydroxamic acids as therapeutic agents

Compounds of formula (I): where the substituents are as defined herein, and salts thereof, are matrix metalloprotease inhibitors.

Inhibitors of protein farnesyltransferase and squalene synthase

The present invention provides a compound of the formula STR1 or a pharmaceutically acceptable salt thereof, which are useful in inhibiting protein farnesyltransferase and the farnesylation of the oncogene protein Ras or inhibiting de novo squalene production resulting in the inhibition of cholesterol biosynthesis, processes for the preparation of the compounds of the invention in addition to intermediates useful in these processes, a pharmaceutical composition, and to methods of using such compounds.